Pedro Moro

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA
    Expert Rev Vaccines 11:911-21. 2012
  2. doi request reprint Echinococcosis: a review
    Pedro Moro
    Immunization Safety Office, Office of the Director, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, Georgia 30333, USA
    Int J Infect Dis 13:125-33. 2009
  3. ncbi request reprint Short report: serologic evidence of human ehrlichiosis in Peru
    Pedro L Moro
    Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Trop Med Hyg 80:242-4. 2009
  4. doi request reprint Molecular identification of Echinococcus isolates from Peru
    Pedro L Moro
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Parasitol Int 58:184-6. 2009
  5. pmc Economic impact of cystic echinococcosis in peru
    Pedro L Moro
    Division of Healthcare Quality Promotion, Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS Negl Trop Dis 5:e1179. 2011
  6. doi request reprint Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 205:473.e1-9. 2011
  7. ncbi request reprint Cystic echinococcosis in the Americas
    Pedro Moro
    Immunization Safety Office, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Parasitol Int 55:S181-6. 2006
  8. doi request reprint Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003
    David L Swerdlow
    Smallpox Vaccine Adverse Events Monitoring and Response Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 46:S234-41. 2008

Detail Information

Publications8

  1. ncbi request reprint Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA
    Expert Rev Vaccines 11:911-21. 2012
    ..This review summarizes US and international safety data for influenza vaccines in pregnant women with an emphasis on 2009 H1N1 influenza vaccines...
  2. doi request reprint Echinococcosis: a review
    Pedro Moro
    Immunization Safety Office, Office of the Director, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, Georgia 30333, USA
    Int J Infect Dis 13:125-33. 2009
    ..Despite some progress in the control of echinococcosis, this zoonosis continues to be a major public health problem in several countries, and in several others it constitutes an emerging and re-emerging disease...
  3. ncbi request reprint Short report: serologic evidence of human ehrlichiosis in Peru
    Pedro L Moro
    Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Trop Med Hyg 80:242-4. 2009
    ..phagocytophilum. These findings suggest that human infection with E. chaffeensis occurs in Peru. Further studies are needed to characterize Ehrlichia species in Peru, their vectors and their clinical significance...
  4. doi request reprint Molecular identification of Echinococcus isolates from Peru
    Pedro L Moro
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Parasitol Int 58:184-6. 2009
    ..canadensis camel strain) was found in goats and in one human patient. These findings may inform prevention strategies and control programs against echinococcosis in Peru...
  5. pmc Economic impact of cystic echinococcosis in peru
    Pedro L Moro
    Division of Healthcare Quality Promotion, Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS Negl Trop Dis 5:e1179. 2011
    ..Cystic echinococcosis (CE) constitutes an important public health problem in Peru. However, no studies have attempted to estimate the monetary and non-monetary impact of CE in Peruvian society...
  6. doi request reprint Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 205:473.e1-9. 2011
    ....
  7. ncbi request reprint Cystic echinococcosis in the Americas
    Pedro Moro
    Immunization Safety Office, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Parasitol Int 55:S181-6. 2006
    ..Here we review the historical and current distribution and prevalence of these infections throughout the American countries and the results of programs to control or eliminate the infection...
  8. doi request reprint Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003
    David L Swerdlow
    Smallpox Vaccine Adverse Events Monitoring and Response Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 46:S234-41. 2008
    ..10; 95% PI, 3.5-15.7). After persons with >/=3 cardiac risk factors or known heart disease were deferred from vaccination, no ICEs were reported among an additional 6638 vaccinees...